NDC11 64980020905
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 64980-0209-05 | 64980-0209 |
| 64980-0209-5 | 64980-0209 |
| 64980-209-05 | 64980-209 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Rising Pharma Holdings, Inc. | ab431781-3183-4638-b656-f40a61f07940 | 2025-05-19 | Warnings, Adverse reactions | 64980-209-05 64980-209 64980020905 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.